Aside from the classical cannabinoid receptors, PPAR isoforms (PPAR-α, PPAR-β/δ, and PPAR-γ) have also been found to play key roles in in vitro and mice models of NAFLD by regulating adipogenesis and inhibiting liver fibrosis [40,50]. Here, PPARA is linked to metabolic dysfunction-associated steatotic liver disease.